Cross-institution positioning
Mar 27, 2026Reduction leaning. 1 accumulating, 1 reducing across 2 comparable institutions.
Source: Schedule 13 researchSylvamo Corp
Latest stored close $32.65 as of Oct 9, 2026 View live quote ↗
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Reduction leaning. 1 accumulating, 1 reducing across 2 comparable institutions.
Source: Schedule 13 research2 increased/new, 0 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsOver the last 90 days, SEC-coded non-derivative P/S activity includes 0 purchases by 0 reporting owners and 1 sale by 1 reporting owner. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/51 non-amendment material event in the last 90 days; Latest classified evidence: Results of operations / financial condition. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue +1.5% YoY; Net income -173.3% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 3% through its reported 52-week range; -21.1% over one year.
Source: Stored historical price seriesFiled Mar 27, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Ferguson Kevin W | FTax/price withholding or payment | Common Stock | 78 | $35.92 | Direct | Sep 2, 2026 |
| Jul 28, 2026 | Zallie James P. | AGrant, award, or other acquisition · derivative | Dividend Equivalent Units | 45 | $38.92 | Direct | Jul 30, 2026 |
| Jul 28, 2026 | PETRATIS DAVID D | AGrant, award, or other acquisition · derivative | Deferred Stock Units | 464 | $38.92 | Direct | Jul 30, 2026 |
| Jul 28, 2026 | JOHNSON JOIA M | AGrant, award, or other acquisition · derivative | Dividend Equivalent Units | 45 | $38.92 | Direct | Jul 30, 2026 |
| Jul 28, 2026 | JOHNSON JOIA M | AGrant, award, or other acquisition · derivative | Deferred Stock Units | 161 | $38.92 | Direct | Jul 30, 2026 |
| Jul 28, 2026 | Desmond Jeanmarie F. | AGrant, award, or other acquisition · derivative | Deferred Stock Units | 136 | $38.92 | Direct | Jul 30, 2026 |
| Jul 28, 2026 | Bruce Lizanne M | AGrant, award, or other acquisition · derivative | Dividend Equivalent Units | 45 | $38.92 | Direct | Jul 30, 2026 |
| Jul 28, 2026 | Breves Christine S | AGrant, award, or other acquisition · derivative | Dividend Equivalent Units | 45 | $38.92 | Direct | Jul 30, 2026 |
| Jul 28, 2026 | Breves Christine S | AGrant, award, or other acquisition · derivative | Deferred Stock Units | 68 | $38.92 | Direct | Jul 30, 2026 |
| Jul 28, 2026 | Wilczynski Patrick | AGrant, award, or other acquisition · derivative | Dividend Equivalent Units | 96 | $38.92 | Direct | Jul 30, 2026 |
| Jul 28, 2026 | Vargas Marcia | AGrant, award, or other acquisition · derivative | Dividend Equivalent Units | 101 | $38.92 | Direct | Jul 30, 2026 |
| Jul 28, 2026 | SIMS JOHN V | AGrant, award, or other acquisition · derivative | Dividend Equivalent Units | 576 | $38.92 | Direct | Jul 30, 2026 |
| Jul 28, 2026 | Lawson Shawn | AGrant, award, or other acquisition · derivative | Dividend Equivalent Units | 156 | $38.92 | Direct | Jul 30, 2026 |
| Jul 28, 2026 | Kalman Hirschfeld Tatiana | AGrant, award, or other acquisition · derivative | Dividend Equivalent Units | 176 | $38.92 | Direct | Jul 30, 2026 |
| Jul 28, 2026 | Ferguson Kevin W | AGrant, award, or other acquisition · derivative | Dividend Equivalent Units | 70 | $38.92 | Direct | Jul 30, 2026 |
| Jul 28, 2026 | Devlin Donald P. | AGrant, award, or other acquisition · derivative | Dividend Equivalent Units | 280 | $38.92 | Direct | Jul 30, 2026 |
| Jul 28, 2026 | Davoli Rodrigo | AGrant, award, or other acquisition · derivative | Dividend Equivalent Units | 252 | $38.92 | Direct | Jul 30, 2026 |
| Jul 28, 2026 | Barron Matthew | AGrant, award, or other acquisition · derivative | Dividend Equivalent Units | 177 | $38.92 | Direct | Jul 30, 2026 |
| Jun 15, 2026 | Bruce Lizanne M | SOpen-market or private sale | Common Stock | 1.2K | $41.70 | Direct | Jun 16, 2026 |
| Jun 1, 2026 | Lawson Shawn | FTax/price withholding or payment | Common Stock | 980 | $39.27 | Direct | Jun 2, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Aug 7, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| May 18, 2026 | 8-K | 5.07 | Shareholder vote results | — | Filing |
| May 8, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Mar 6, 2026 | S-3ASR | — | Shelf securities registration | Capital-related | Filing |
| Feb 12, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Dec 17, 2025 | 8-K/AAmendment | 5.02, 7.01, 9.01 | Director or executive change; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Nov 10, 2025 | 8-K | 1.01, 3.03, 5.03, 8.01, 9.01 | Material definitive agreement; Material modification of security-holder rights; Charter or bylaw change; Other event; Financial statements / exhibits | Equity | Filing |
| Nov 7, 2025 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Nov 6, 2025 | 8-K | 5.02 | Director or executive change | — | Filing |
| Oct 29, 2025 | 8-K | 1.01, 1.02, 9.01 | Material definitive agreement; Termination of material agreement; Financial statements / exhibits | — | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Jun 30, 2026 | $806.0M | +1.5% |
| Ended Mar 31, 2026 | $755.0M | -8.0% |
| Ended Sep 30, 2025 | $846.0M | -12.3% |
| Ended Jun 30, 2025 | $794.0M | -14.9% |
| Period | Revenue | YoY |
|---|---|---|
| Ended Dec 31, 2025 | $3.4B | -11.2% |
| Ended Dec 31, 2024 | $3.8B | +1.4% |
| Ended Dec 31, 2023 | $3.7B | +2.6% |
| Ended Dec 31, 2022 | $3.6B | +28.3% |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Vanguard Group CIK0000102909 | Mar 13, 2026 observed Mar 27, 2026 filed · 14d Schedule 13G amendment | Reported reduction | 11 -3.1M | 12.00% +4.49 pts | $41.51 | $40.13 | $32.65 |
| Vanguard Group CIK0000102909 | Jun 30, 2025 observed Jul 29, 2025 filed · 29d Schedule 13G amendment | Reported accumulation | 3.1M +367.4K | 7.51% +1.03 pts | $50.10 | $48.13 | $32.65 |
| BlackRock CIK0001364742 | Dec 31, 2023 observed Jan 23, 2024 filed · 23d Schedule 13G amendment | Reported accumulation | 5.8M +201.3K | 13.90% +1.30 pts | $49.11 | $49.00 | $32.65 |
Compare SLVM with other securities showing similar institutional activity or recent accumulation across several tracked institutions.